Affitech secures bridge financing

Tuesday 5 January 2010

The Danish antibody developer, Affitech A/S, has negotiated a bridging loan of DKK 9.33 million (€1.25 million) to cover its needs while it negotiates a larger financing during the first quarter. The loan has been extended by three existing investors.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Denmark